[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-339869-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-339869-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","boron-neutron-capture-therapy-delays-the-decline-in-neurological-function-in-a-mouse-model-of-metastatic-spinal-tumors","Boron neutron capture therapy delays the decline in neurological function in a mouse model of metastatic spinal tumors","","Metastatic spinal tumors are increasingly common as cancer treatments improve survival, creating a pressing need for therapies that control malignancy while preserving neurological function. This study evaluates boron neutron capture therapy (BNCT) using a mouse model of metastatic spinal tumors induced by A549 human lung adenocarcinoma cells, comparing untreated, neutron-only, and BNCT groups. BNCT significantly prolonged survival and preserved hindlimb neurological function with no observed adverse events, supporting BNCT as a promising option for spine metastases.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/boron-neutron-capture-therapy-delays-the-decline-in-neurological-function-in-a-mouse-model-of-metastatic-spinal-tumors/339869/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/boron-neutron-capture-therapy-delays-the-decline-in-neurological-function-in-a-mouse-model-of-metastatic-spinal-tumors/339869.png","ImageObject",300,407,{"name":42,"@type":43},"Ezra","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-01","2026-09-21",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",7,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is the main goal of this study?","Question",{"text":63,"@type":64},"To evaluate the efficacy and safety of boron neutron capture therapy (BNCT) for spine metastases in a mouse model, focusing on survival and neurological function outcomes.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How was BNCT delivered and what were the comparison groups?",{"text":68,"@type":64},"Mice received 4-borono-L-phenylalanine intravenously and then received measurements of boron concentrations; groups included untreated, neutron irradiation only, and BNCT.",{"name":70,"@type":61,"acceptedAnswer":71},"What were the key results regarding survival and neurological function?",{"text":72,"@type":64},"The BNCT group showed significantly prolonged survival and preserved hindlimb neurological function compared with untreated and neutron-only groups.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},339869,1790189233,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":112,"preview_page_count":33,"preview_urls":145},1099514068035,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","DOI: 10. 1111/cas.16245  \nOR I G I NAL ART I C L E  \nBoron neutron capture therapy delays the decline in neurological function in a mouse model of metastatic spinal tumors  \nYoshiki Fujikawa1  | Shinji Kawabata1  | Kohei Tsujino1  | Hironori Yamada1 | Hideki Kashiwagi1  | Ryokichi Yagi1 | Ryo Hiramatsu1  | Naosuke Nonoguchi1 | Toshihiro Takami1 | Akinori Sasaki2 | Naonori Hu2  | Takushi Takata3 |  \nHiroki Tanaka3  | Minoru Suzuki3 | Masahiko Wanibuchi1   \n1Department of Neurosurgery, Osaka Medical and Pharmaceutical University, Osaka, Japan  \n2Kansai BNCT Medical Center, Osaka Medical and Pharmaceutical University, Osaka, Japan  \n3 Institute for Integrated Radiation and Nuclear Science, Kyoto University, Osaka, Japan  \nCorrespondence  \nShinji Kawabata, Department of Neurosurgery, Osaka Medical and Pharmaceutical University, 2-7 Daigakumachi, Takatsuki, Osaka 569-8686, Japan.  \nEmail: [shinji.kawabata@ompu.ac.jp](shinji.kawabata@ompu.ac.jp)  \nFunding information  \nJapan Society for the Promotion of Science, Grant/Award Number:  \nJP22K09270 and JP23H03024  \nAbstract  \nMetastatic spinal tumors are increasingly prevalent due to advancements in cancer treatment, leading to prolonged survival rates. This rising prevalence highlights the need for developing more effective therapeutic approaches to address this malignancy. Boron neutron capture therapy (BNCT) offers a promising solution by delivering targeted doses to tumors while minimizing damage to normal tissue. In this study, we evaluated the efficacy and safety of BNCT as a potential therapeutic option for spine metastases in mouse models induced by A549 human lung adenocarcinoma cells. The animal models were randomly allocated into three groups: untreated (n = 10), neutron irradiation only (n = 9), and BNCT (n = 10) . Each mouse was administered 4-borono-L-phenylalanine (250 mg/kg) intravenously, followed by measurement of boron concentrations 2.5 h later. Overall survival, neurological function of the hindlimb, and any adverse events were assessed post irradiation. The tumor-to-normal spinal cord and blood boron concentration ratios were 3.6 and 2.9, respectively, with no significant difference observed between the normal and compressed spinal cord tissues. The BNCT group exhibited significantly prolonged survival rates compared with the other groups (vs. untreated, p = 0.0015; vs. neutron-only, p = 0.0104, log-rank test) . Furthermore, the BNCT group demonstrated preserved neurological function relative to the other groups (vs. untreated, p = 0.0004; vs. neutron-only, p = 0.0051, multivariate analysis of variance) . No adverse events were observed post irradiation. These findings indicate that BNCT holds promise as a novel treatment modality for metastatic spinal tumors.  \nAbbreviations: BBB, Basso–Beattie–Bresnahan; BNCT, boron neutron capture therapy; BPA, 4-borono-L-phenylalanine; CBE, compound biological effectiveness; CI, confidence interval; CT, computed tomography; DB, boron dose; DN, nitrogen dose; DH, hydrogen dose; Dγ, gamma-ray dose; ESCC, epidural spinal cord compression; Gy-Eq, photon-equivalent dose; ICP-AES, inductively coupled plasma–atomic emission spectroscopy; KURNS, Kyoto University Institute for Integrated Radiation and Nuclear Science; LAT, L-type amino acid transporter; MANOVA, multivariate analysis of variance; MST, median survival time; QOL, quality of life; RBE, relative biological effectiveness; SF, surviving fraction; SBRT, stereotactic body radiation therapy; T/N, tumor-to-normal tissue ratio; T/Bl, tumor-to-blood ratio.  \nThis is an open access article under the terms of the Creative Commons Attribution-NonCommercial License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.  \n© 2024 The Author(s) . Cancer Science published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association.  \nK E Y WO R D S  \n4-borono-L-phenylalanine, bor","cbCaidJOr3Iwey8W","https://ap.wps.com/l/cbCaidJOr3Iwey8W","pdf",4854309,12,"English","# Abstract\n## Introduction\n## Study Rationale and Aim","[{\"question\":\"What is the main goal of this study?\",\"answer\":\"To evaluate the efficacy and safety of boron neutron capture therapy (BNCT) for spine metastases in a mouse model, focusing on survival and neurological function outcomes.\"},{\"question\":\"How was BNCT delivered and what were the comparison groups?\",\"answer\":\"Mice received 4-borono-L-phenylalanine intravenously and then received measurements of boron concentrations; groups included untreated, neutron irradiation only, and BNCT.\"},{\"question\":\"What were the key results regarding survival and neurological function?\",\"answer\":\"The BNCT group showed significantly prolonged survival and preserved hindlimb neurological function compared with untreated and neutron-only groups.\"}]","Boron neutron capture therapy delays the decline in neurological function in a mouse model of metastatic spinal tumors | PDF",1790032850,[146,150,154,158],{"page_no":22,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0dcfde00f65d3bc91d0402b758bdb67c.webp",983,1291,{"page_no":26,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8956a31e98932fb04709b9479b1972cc.webp",982,1290,{"page_no":30,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9c304670737332f4d4c5fee05a414ae4.webp",981,1289,{"page_no":33,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1d0678bc0ee3bd198218800354829874.webp",980,1287]